Uncertainty quantification and multi-stage variable selection for personalized treatment regimes
个性化治疗方案的贝叶斯不确定性量化与多阶段变量选择AI 解读 ↓
本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。
DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。
本页为预印本版本;arXiv 收录、作者填写的期刊信息以及作者既有发表经历,都不单独证明本篇已接收。作者发表记录按 OpenAlex 身份与完整姓名、本站覆盖期刊 ISSN 及正式卷期核对,只展示已核实例,档案仍可能误合并。
引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。
关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。
AI 根据所提供的论文材料归类:摘要聚焦动态治疗方案、反事实变量与最优治疗序列的识别,属于因果推断框架下的个体化处理效应问题。
个性化治疗方案的贝叶斯不确定性量化与多阶段变量选择AI 解读 ↓
正在核对关联版本…
正在核对对应版本的资源…
A dynamic treatment regime is a sequence of medical decisions that adapts to the evolving clinical status of a patient over time. To facilitate personalized care, it is crucial to assess the probability of each available treatment option being optimal for a specific patient, while also identifying the key prognostic factors that determine the optimal sequence of treatments. This task has become increasingly challenging due to the growing number of individual prognostic factors typically available. In response to these challenges, we propose a Bayesian model for optimizing dynamic treatment regimes that addresses the uncertainty in identifying optimal decision sequences and incorporates dimensionality reduction to manage high-dimensional individual covariates. The first task is achieved through a suitable augmentation of the model to handle counterfactual variables. For the second, we introduce a novel class of spike-and-slab priors for the multi-stage selection of significant factors, to favor the sharing of information across stages. The effectiveness of the proposed approach is demonstrated through extensive simulation studies and illustrated using clinical trial data on severe acute arterial hypertension.
基于贝叶斯机器学习的决策论亚组发现
We consider the problem of identifying promising subpopulations in terms of treatment effectiveness or treatment effect heterogeneity, from a Bayesian decision theoretic perspective. We first show that a straight-forward application of Bayesian decision theory to subgroup detection leads to a counter-intuitive risk-seeking (RS) behavior. Motivated by this observation, we introduce the Bayesian Risk-Aware Inference and Detection of Subgroups (BRAIDS) utility and use it to…
目标函数平衡:利用策略性不平衡估计因果效应
When estimating the average treatment effect of a binary intervention with weights, investigators are often burdened with how best to leave imbalance in the distributions of observed covariates. This requires that investigators proceed cautiously, as imbalance in key (nonlinear transformations of) covariates potentially introduces bias into the ultimate estimated effect. This paper introduces Targeted Function Balancing (TFB), a flexible covariate balancing weights approach…
带工具变量的收缩贝叶斯因果森林
Discovering interpretable subgroups whose complier effects deviate from the average is a central goal of instrumental variable analysis under imperfect compliance, yet existing tree-based methods degrade when most covariates are irrelevant to the effect. We propose Shrinkage Bayesian Causal Forest with Instrumental Variable (SBCF-IV) for discovering and estimating subgroups with heterogeneous Complier Average Causal Effects (CACE) in sparse high-dimensional settings. SBCF-IV…
广义贝叶斯政策学习
This study proposes a General Bayes framework for policy learning. We consider decision problems in which a decision-maker chooses an action from a given set to maximize expected welfare. Typical examples include treatment choice and portfolio optimization. In such problems, the statistical target is a decision rule, and predicting each potential outcome is not necessarily of primary interest. We formulate this policy-learning problem through loss-based Bayesian updating.…
交错双重差分中的部分同质性
In staggered difference-in-differences (DiD) designs, units enter treatment at different calendar times, so the treatment effect is not a single number but a set of Cohort-Average Treatment effects on the Treated (CATTs), one per cohort-time cell. Estimating every CATT as its own parameter, as the standard fully flexible estimator does, is unbiased but inefficient when some of these effects are in fact equal, whereas pooling them all into a single two-way fixed effects…
事件时间结果因果亚组估计的贝叶斯层级自助框架
Causal estimation of treatment effects within prespecified subgroups, such as biomarker-defined strata, disease phenotypes, or demographic groups are often of clinical interest. Bayesian approaches are attractive for subgroup effect estimation because flexible priors can represent complex treatment heterogeneity and propagate posterior uncertainty. Frequentist methods for prespecified causal subgroup analysis with time-to-event outcomes are also available, including…